NOVT
Q4 2026 EPS Estimate
$0.97
Nov 2, 2026
Revenue Estimate
$301M
FY2026E EPS$3.59
FY2027E EPS$4.14

Analyst Sentiment

Wall St. Consensus
Buy
3 analysts·Low coverage
67
Score
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
267%
Hold
133%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$194.00
+16.1%
Consensus
$194.00
+16.1%
Bull
$194.00
+16.1%
12-Month Target Range3 analysts
$194.00$194.00$194.00
Current $167.04Consensus
Current Price
$167.04
Upside to Consensus
$26.96

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+6.82%
EPS+15.41%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$1.05B$1.13B
Low$1.05B$1.12B
High$1.06B$1.14B
EBITDA Avg$190M$203M
Low$190M$203M
High$191M$205M
EBIT Avg$127M$136M
Low$127M$136M
High$128M$137M
Net Income Avg$132M$152M
Low$130M$151M
High$133M$153M
EPS Avg$3.59$4.14
Low$3.55$4.11
High$3.62$4.16
Analysts (Rev / EPS)2 / 22 / 2
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$263M$270M$266M$267M$267M$267M
Low$263M$269M$265M$265M$265M$266M
High$263M$272M$268M$268M$268M$268M
EBITDA Avg$47M$49M$48M$48M$48M$48M
Low$47M$49M$48M$48M$48M$48M
High$47M$49M$48M$48M$48M$48M
EBIT Avg$32M$33M$32M$32M$32M$32M
Low$32M$33M$32M$32M$32M$32M
High$32M$33M$32M$32M$32M$32M
Net Income Avg$39M$41M$41M$42M$42M$44M
Low$38M$40M$40M$41M$42M$44M
High$39M$42M$41M$42M$43M$44M
EPS Avg$0.94$1.00$0.99$1.01$1.03$1.07
Low$0.93$0.98$0.98$1.00$1.02$1.06
High$0.95$1.01$1.00$1.02$1.04$1.08
Analysts (Rev / EPS)2 / 22 / 21 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Aug 7, 2026Robert W. Baird
Novanta price target raised to $194 from $180 at Baird
Target:$194.00
+15.3%from $168.29
Jun 9, 2026Robert W. Baird
Novanta price target raised to $180 from $173 at Baird
Target:$180.00
+9.5%from $164.34
Feb 25, 2026Robert W. Baird
Novanta price target raised to $150 from $138 at Baird
Target:$150.00
+11.4%from $134.67
Mar 3, 2025Robert W. Baird
Novanta price target lowered to $160 from $169 at Baird
Target:$160.00
+11.6%from $143.37
Aug 7, 2024Robert W. Baird
Novanta price target raised to $175 from $170 at Baird
Target:$175.00
+0.4%from $174.36
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.